Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Post by jopatcloon Aug 07, 2024 7:30am
101 Views
Post# 36167108

17th EUROPEAN ECHOCARDIOGRAPHY COURSESeptember 11th-13th, 24

17th EUROPEAN ECHOCARDIOGRAPHY COURSESeptember 11th-13th, 2417th EUROPEAN ECHOCARDIOGRAPHY 
COURSE
on congenital heart disease COPENHAGEN
17th EUROPEAN ECHOCARDIOGRAPHY 
COURSE September 11th-13th, 2024

--Wednesday, September 11th, 2024 08.20 Opening remarks Annette Schophuus Jensen, Copenhagen Jan Marek, London Luc Mertens, Toronto
-Session IV: Atrioventricular septal defects Chair: Luc Mertens, Toronto 14.30 Morphological aspect of AVSD Andrew Cook, London 14.55 Echocardiographic assessment of AVSD Meryl Cohen, Philadelphia 15.20 Surgical aspects of AVSD repair Viktor Hraska, Milwaukee 15.45 Q&A 15.55 Coffee break

--Thursday, September 12th, 2024 Session V: Tetralogy of Fallot Chair: Meryl Cohen, Philadelphia 08.30 Morphology of Tetralogy of Fallot Andrew Cook, London 08.55 Pre-operative assessment of Tetralogy of Fallot Luc Mertens, Toronto 09.20 Surgical repair of TOF Viktor Hraska, Milwaukee 09.45 The adult patient long-term after TOF repair Heleen van der Zwaan, Utrecht 10.10 Q&A 10.20 Coffee break
-Session VI: Transposition of the great arteries Chair: John Simpson, London 11.00 Morphology of transposition Andrew Cook, London 11.25 Pre-operative assessment Paolo Ciliberti, Roma 11.50 Surgical perspective – arterial switch Viktor Hraska, Milwaukee 12.15 Post-operative course after arterial switch Luc Mertens, Toronto 12.40 Q&A 12.50-14.00 Lunch 13.15-14.00 Satellite mini-symposium PHILIPS Assessment of ASD’s and VSDs by 3D echocardiography not accredited EBAC 14.00 Live scanning session PHILIPS not accredited EBAC

--Friday, September 13th, 2024 Session VIII: Functionally univentricular hearts Chair: Luc Mertens, Toronto 08.30 Morphology of functionally univentricular hearts Andrew Cook, London 08.55 Preoperative echocardiography Meryl Cohen, Philadelphia 09.20 Surgical strategies in single ventricular palliation Viktor Hraska, Milwaukee 09.45 Echo assessment of staged palliation strategy Leo Lopez, Stanford 10.10 Q&A 10.30 Coffee break

-Case session Chair: Jan Marek, London 15.00 History: a 50 years old Fontan patient Heleen van der Zwaan, Utrecht 15.15 Future: Ultrafast ultrasound in clinical practice Luc Mertens, Toronto 15.30 Closing remarks Jan Marek, Luc Mertens, Folkert Meijboom
<< Previous
Bullboard Posts
Next >>